ACTIVE

VITAPO

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result104 k €-13,1 %over 1 year
Gross margin112,5 k €+9,2 %over 1 year
Equity763,2 k €+11,5 %over 1 year

Identity

Source · BCE/KBO

VITAPO is a Private limited company incorporated in 2015. Its main activity is: Activities of holding companies. Its registered office is in Vorselaar.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0638.890.597
Incorporation
28/09/2015
Legal form
Private limited company
Registered office
Kerkstraat 18
2290 Vorselaar · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

Financials

Source · NBB, 10 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin112,5 k €103 k €102,5 k €103,4 k €108 k €
EBITDA111,2 k €101,7 k €100,3 k €102,3 k €107 k €
Operating result110,2 k €100,8 k €100 k €102,3 k €107 k €
Net result104 k €119,7 k €114,2 k €64,5 k €346,4 k €
Balance sheet
Equity763,2 k €684,5 k €564,8 k €565,6 k €616,1 k €
Total assets1,3 M €1,3 M €1,3 M €1,3 M €1,4 M €
Cash13,1 k €5,8 k €5,1 k €12 k €16,8 k €
Debts530,2 k €622,9 k €773,2 k €769,1 k €749,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

MJ Pharma

Bestuurder · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Active

Ended mandates

MJ Pharma

Director · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Ended
MJ Pharma BV

Bestuurder · since 14 octobre 2020

Represented by Julie Schyvens

Ended
Caroline Verlinden

Director

Ended
Caroline Verlinden

Manager

Ended

Other companies at this address

Kerkstraat 18 2290 Vorselaar
CompanyCBE no.
apotheek Schyvens● Active
0404.191.575
MJ Pharma● Active
0755.612.578

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/07/202631/07/202530/07/202429/06/202320/07/202222/07/2021
General meeting19/06/202620/06/202530/06/202416/06/202317/06/202218/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202519/06/202616/07/2026DutchPDF
Abridged model31/12/202420/06/202531/07/2025DutchPDF
Abridged model31/12/202330/06/202430/07/2024DutchPDF
Abridged model31/12/202216/06/202329/06/2023DutchPDF
Abridged model31/12/202117/06/202220/07/2022DutchPDF
Abridged model31/12/202018/06/202122/07/2021DutchPDF
Abridged model31/12/201919/06/202024/07/2020DutchPDF
Abridged model31/12/201821/06/201902/08/2019DutchPDF
Abridged model31/12/201715/06/201820/07/2018DutchPDF
Abridged model31/12/201616/06/201731/08/2017DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

MJ Pharma

Bestuurder · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Active

Ended mandates

MJ Pharma

Director · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Ended
MJ Pharma BV

Bestuurder · since 14 octobre 2020

Represented by Julie Schyvens

Ended
Caroline Verlinden

Director

Ended
Caroline Verlinden

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other08/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Mandates23/10/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/02/2016
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other30/09/2015
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025104 k €↓
  2. 2024
    Annual accounts 2024119,7 k €↑
  3. 2023
    Annual accounts 2023114,2 k €↑
  4. 2022
    Annual accounts 202264,5 k €↓
  5. 2021
    Annual accounts 2021346,4 k €
  6. 28/09/2015
    IncorporationPrivate limited company